Maximum Daily Dose of Telmisartan
The maximum recommended daily dose of telmisartan is 80 mg once daily 1, 2, 3.
Dosing Guidelines
For Hypertension
- Starting dose: 40 mg once daily 3
- Dose range: 20-80 mg daily 1, 2
- Maximum dose: 80 mg once daily 1, 2, 3
Blood pressure response is dose-related across the 20-80 mg range, with most antihypertensive effect apparent within 2 weeks and maximal reduction generally attained after 4 weeks 3. The evidence consistently shows that 80 mg represents the ceiling dose, as larger dosages do not provide additional blood pressure lowering benefit 4, 5.
For Cardiovascular Risk Reduction
- Recommended dose: 80 mg once daily 3
- It is not known whether doses lower than 80 mg are effective for cardiovascular risk reduction 3
This indication applies to patients ≥55 years at high cardiovascular risk who cannot take ACE inhibitors, including those with coronary artery disease, peripheral arterial disease, stroke, or high-risk diabetes with end-organ damage 3.
Key Clinical Considerations
Dosing frequency: Telmisartan is administered once daily and may be taken with or without food 3. Its extremely long half-life of 20-30 hours maintains efficacy throughout the 24-hour period 4.
Special populations:
- Elderly patients: No initial dosage adjustment necessary 3
- Renal impairment/dialysis: No initial adjustment required, though patients on dialysis may develop orthostatic hypotension and require close blood pressure monitoring 3
- Hepatic insufficiency: Initiate at low doses and titrate slowly due to reduced biliary clearance 3
Evidence from Major Trials
The ONTARGET trial, which enrolled 25,620 high-risk patients, used telmisartan 80 mg daily and demonstrated non-inferiority to ramipril 10 mg daily for cardiovascular outcomes 6, 7. Similarly, both TRANSCEND and PRoFESS trials used telmisartan 80 mg daily as the therapeutic dose 8.
Important caveat: The 2020 ACC/AHA heart failure guidelines list telmisartan 80 mg once daily as the target dose for heart failure with reduced ejection fraction, with 40 mg representing 50% of the target dose 9. This reinforces that 80 mg is the established maximum therapeutic dose across cardiovascular indications.
Do not exceed 80 mg daily - doses above this threshold have not demonstrated additional efficacy and are not FDA-approved 3, 5.